Timothy Mayopoulos Acquires 50,000 Shares of BLND
Timothy Mayopoulos made a notable purchase of BLND shares, adding 50,000 to his holdings.
Key Points
- Timothy Mayopoulos purchased 50,000 shares of BLND on June 11, 2026.
- BLND's stock traded at $1.69 with notable institutional interest from firms like BlackRock and Vanguard.
- Analysts from firms like Canaccord Genuity and Citizens maintained buy ratings on BLND.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Timothy Mayopoulos, a key figure associated with BLND, bought 50,000 shares of the company on June 11, 2026. This insider transaction reflects his confidence in BLND, though the specific purchase price wasn't disclosed.
Other Institutional Activity in BLND
Several major institutional investors have been active in BLND. Lightspeed Management Company, L.L.C. held steady with 23.1 million shares valued at about $39.3 million. BlackRock, Inc. trimmed its position by 65,730 shares, leaving it with 16.3 million shares worth approximately $27.7 million. Cypress Point Investment Management LP significantly increased its stake by 2.7 million shares, now holding 14.5 million shares valued at $24.7 million. Vanguard Capital Management LLC entered the scene with 9.7 million shares, worth around $16.4 million.
Blend Labs, Inc. Stock Up 11.2%
Shares of BLND traded at around $1.69. While specific financial ratios like P/E are not available, the stock's activity and insider transactions suggest a dynamic interest from both insiders and institutional investors.
Insider Buying and Selling at Blend Labs, Inc.
On June 11, 2026, several insiders were active in trading BLND shares. Timothy Mayopoulos acquired 50,000 shares, while Eric Woersching also purchased the same amount. Conversely, insiders like Gerald Chen, Erin Lantz, and Bryan Edmund Sullivan each sold 50,000 shares. These transactions were not part of any pre-planned trading programs.
Analysts Set New Price Targets
On May 15, 2026, Canaccord Genuity maintained a 'buy' rating for BLND with a price target of $4.50. Earlier in May, Citizens also kept a 'buy' rating with a $4.00 target. Keefe, Bruyette & Woods rated the stock as 'hold,' setting a target at $1.90. UBS and Wells Fargo also maintained their ratings, reflecting a mix of optimism and caution in the analyst community.
Bottom Line
Timothy Mayopoulos's recent purchase of 50,000 BLND shares highlights ongoing insider interest in the company. Institutional investors like BlackRock and Vanguard are actively adjusting their positions, indicating varied strategies. Analyst ratings remain mixed, providing a range of perspectives on BLND's potential. As always with 13F filings and insider trades, these insights reflect past actions and might not represent current positions.
Get Blend Labs, Inc. alerts
New 13F filings, insider trades, and analyst moves on $BLND, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.